Calcium channel blockers.
D000787:Angina Pectoris / Q000188:drug therapy / Q000378:metabolism; D000788:Angina Pectoris, Variant / Q000188:drug therapy / Q000378:metabolism; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004110:Diltiazem / Q000378:metabolism / Q000627:therapeutic use; D006207:Half-Life; D006331:Heart Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism; D007700:Kinetics; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism; D009543:Nifedipine / Q000378:metabolism / Q000627:therapeutic use; D010480:Perhexiline / Q000378:metabolism / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000378:metabolism / Q000627:therapeutic use; D014700:Verapamil / Q000378:metabolism / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D010480:Perhexiline